Summary:
Psychiatric Care and Research Center is conducting a multi-center, randomized, double-blind, placebo controlled study to investigate the efficacy and safety of Trintellix in the treatment of adolescent depression. There will be three treatment arms and one placebo arm. Trintellix is a new antidepressant that has been approved for use in adults and this study is to determine its usefulness in severely depressed adolescents.
Qualified Participants Must:
• Be between 12 and 17 years of age
•
Have significant depression
•
Not have a first degree relative who had Bipolar Disorder
Qualified Participants May Receive:
Compensation for time and travel may be possible.
Complete physical examination.